Join
Live feed
·
INSIDERFilingvia Quantisnow
Zentalis Pharmaceuticals Inc. logo

SEC Form 4: Gallagher Cam sold $237,760 worth of shares (11,833 units at $20.09) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 491,270 units to satisfy withholding tax

ByQuantisnow·Wall Street's wire, on your screen.
ZNTL· Zentalis Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZNTL (Zentalis Pharmaceuticals Inc.) and more on Quantisnow.